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Abstract 
Keratinocyte mobilization is a critical aspect of wound re-epithelialization, but the mechanisms that 
control its precise regulation remain poorly understood. We set out to test the hypothesis that forkhead 
box O1 (FOXO1) has a negative effect on healing because of its capacity to inhibit proliferation and 
promote apoptosis. Contrary to expectations, FOXO1 is required for keratinocyte transition to a wound-
healing phenotype that involves increased migration and up-regulation of transforming growth factor β1 
(TGF-β1) and its downstream targets, integrin-α3 and -β6 and MMP-3 and -9. Furthermore, we show that 
FOXO1 functions in keratinocytes to reduce oxidative stress, which is necessary to maintain cell migration 
and prevent cell death in a TGF-β1–independent manner. Thus, our studies identify a novel function for 
FOXO1 in coordinating the response of keratinocytes to wounding through up-regulation of TGF-β1 and 
other factors needed for keratinocyte migration and protection against oxidative stress, which together 
promote migration and decrease apoptosis. 
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Introduction
Cutaneous wound healing is a highly coordinated multistep pro-
cess that involves inflammation, re-epithelialization, granulation 
tissue formation, remodeling of basement membrane and extra-
cellular matrix, and dermal and epidermal maturation. The initial 
inflammatory response stimulates the release of growth factors 
and chemokines that initiate the later phases of wound repair 
(Singer and Clark, 1999; Martin and Leibovich, 2005; Li et al., 
2007; Raja et al., 2007). The process of wound re-epithelialization 
requires efficient coordination of multiple events, including the 
formation of a provisional wound bed matrix, the migration of 
epidermal keratinocytes into the wound, the proliferation of kera-
tinocytes, and the differentiation of new epithelium into strat-
ified epidermis (Raja et al., 2007).
Keratinocyte migration is critical for re-epithelialization 
and is tightly regulated by various signaling pathways (Ridley 
et al., 2003). After an injury, the basal and suprabasal keratino-
cytes migrate from the wound edge to re-epithelialize the wounded 
tissue (Martin, 1997). However, the transcription factors that acti-
vate and initiate keratinocyte mobilization in response to wound 
healing have not been well established. Keratinocyte migration 
during wound healing is influenced by several factors (Martin, 
1997). An impaired keratinocyte migration, but not defects in 
proliferation or differentiation, is associated with chronic heal-
ing defects and is a limiting factor in wound healing (Raja et al., 
2007). Keratinocyte migration is initiated by various growth fac-
tors including transforming growth factor 1 (TGF-1). TGF-1 
is one of the most extensively studied molecules and its role in 
promoting wound healing is well established (Tsuboi et al., 
1992; Bennett and Schultz, 1993; Werner and Grose, 2003). 
In contrast, some reports suggest that TGF-1 signaling in epider-
mal keratinocytes negatively affected wound healing (Ashcroft 
et al., 1999; Guasch et al., 2007). Activation of TGF-1 leads to 
phosphorylation and nuclear translocation of its downstream 
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K14.Cre.FOXO1L/L mice (P < 0.05; Fig. 1 A). Immunofluorescence 
with FOXO1-specific antibody with histological sections from 
K14.Cre.FOXO1L/L and K14.Cre+.FOXO1L/L mice establish 
an 80% reduction of FOXO1 expression specifically in the epi-
dermis of K14.Cre+.FOXO1L/L compared with littermate con-
trol mice (Fig. 1, B and C). In contrast, there was little difference 
observed in the connective tissue (Fig. 1 B), demonstrating 
lineage-specific deletion in keratinocytes. FOXO1 activation 
in vivo was assessed by nuclear translocation. In keratinocytes 
from normal unwounded tissue, FOXO1 was in the inactivate 
state with 10% of keratinocytes exhibiting FOXO1 nuclear 
localization. Upon wounding, FOXO1 nuclear localization was 
increased over threefold (Fig. 1 D). In contrast, deletion of 
FOXO1 by keratin 14–driven Cre-recombinase reduced its 
nuclear localization by 85% and 82% in keratinocytes of wounded 
and normal epithelium, respectively (Fig. 1 D). For most wounds, 
thickened epithelium and FOXO1 expression returned to basal 
levels within 2.0 mm of the wound edge.
Deletion of FOXO1 in keratinocytes markedly reduced the 
rate of wound healing (Fig. 1, E and F). Wound area was three-
fold larger in K14.Cre+.FOXO1L/L mice compared with K14.
Cre.FOXO1L/L mice on day 3 after wounding (P < 0.05). By day 
7 all the wounds in control mice were healed, but were still open 
in K14.Cre+.FOXO1L/L experimental mice. Moreover, most of 
the control mice showed a high degree of healing on day 4 
whereas most of the K14.Cre+.FOXO1L/L experimental mice did 
not show the same degree of healing until day 7, demonstrating 
considerably delayed healing (Fig. 1 G).
Loss of FOXO1 leads to reduced 
keratinocyte migration but not proliferation
We performed experiments using an in vitro wound-healing assay 
as described in Liang et al. (2007) to assess the direct effect of 
FOXO1 on keratinocyte wound-healing behavior using primary 
normal human epithelial keratinocytes (NHEKs). FOXO1 knock-
down by FOXO1 siRNA was verified by real-time PCR (Fig. 2 A) 
and Western blot analysis (Fig. 2 B). The closure of the scratch 
wound was significantly slower in FOXO1-silenced keratinocytes 
(Fig. S1 A). At each time point examined, FOXO1 knockdown 
caused a 42–70% reduction in the number of keratinocytes filling 
the denuded wound gap compared with cells transfected with 
scrambled siRNA, which was statistically significant (P < 0.05; 
Fig. 2 E and Fig. S1 A). In contrast, knockdown of a related 
FOXO transcription factor, FOXO3, had no effect (P > 0.05; 
Fig. 2, C–E and Fig. S1 A) at any time point under the same 
conditions, nor did scrambled siRNA. Thus, FOXO1 reduction 
in in vitro “wounds” exhibited the same deficit as in vivo wounds 
with FOXO1 deletion. In addition, gain of function by over-
expression of FOXO1 improved the number of keratinocytes 
filling the wound gap significantly compared with keratinocytes 
transfected with empty vector alone (Fig. 2 F).
Epithelial closure of wounds is facilitated by keratinocyte 
proliferation and migration and reduced by apoptosis. Each pa-
rameter was examined separately. Silencing FOXO1 resulted in 
an 80% decrease in keratinocyte migration in a transwell assay 
(P < 0.05; Fig. 2 G and Fig. S1 B). Quantitative real-time PCR 
revealed that FOXO1 knockdown significantly decreased mRNA 
signaling molecules SMAD2/3, which in turn induces target genes 
involved in cell proliferation and migration (Klass et al., 2009). 
TGF-1 promotes keratinocyte migration by stimulating the ex-
pression of various integrins including integrin 6 (Gailit et al., 
1994; Zambruno et al., 1995; Margadant and Sonnenberg, 2010).
Accumulating evidence suggests that reactive oxygen spe-
cies (ROS) such as hydrogen peroxide (H2O2) and superoxide 
(O2) are important regulators of wound healing (Schäfer and 
Werner, 2008). Wound healing induces a small increase in ROS, 
which are removed by protective antioxidant defense mecha-
nisms. Low levels of ROS are essential to stimulate wound heal-
ing (Nishio and Watanabe, 1997; Rodriguez et al., 2008; Guo 
and Dipietro, 2010), whereas high levels result in epithelial cell 
damage and impaired wound repair (Xu et al., 2009).
The forkhead box O1 (FOXO1) transcription factor be-
longs to a large family of forkhead transcription factors that share 
a highly conserved forkhead DNA-binding domain. FOXO1 par-
ticipates in a wide range of cellular processes including cell cycle 
arrest, DNA repair, apoptosis, and oxidative stress resistance 
(Myatt and Lam, 2007; Ho et al., 2008). FOXO1 controls cell 
cycle progression by regulating target genes such as p27Kip1 
and p21 (Medema et al., 2000), apoptosis by regulating target 
genes such as Fas ligand and Bim (Dijkers et al., 2000), and pro-
tects against oxidative stress by up-regulating oxygen radical 
scavengers, such as mnSOD and glutathione peroxidase (van der 
Horst and Burgering, 2007; Storz, 2011). In addition, FOXO1 
protects cells against stress by regulating DNA damage–inducible 
gene 45 (GADD45; Brunet et al., 2004). Loss of FOXO1 can 
increase oxidative stress (Ponugoti et al., 2012). Although FOXO1 
has been shown to be up-regulated in wounds (Siqueira et al., 
2010), its role in wound healing has not been examined.
We investigated the functional impact of FOXO1 deletion 
in normal wound repair by generating keratinocyte-specific 
FOXO1-deficient mice in vivo and by RNAi in primary cultures 
of dermal keratinocytes in vitro. Because FOXO1 inhibits prolif-
eration and promotes apoptosis we hypothesized that FOXO1 
would negatively regulate wound healing. Contrary to our expec-
tations, our results show that FOXO1 is needed to orchestrate the 
cellular events critical to wound healing by promoting keratino-
cyte migration and wound healing primarily through up-regulation 
of TGF-1, but also by protection against oxidative stress 
through a TGF-1–independent mechanism. Thus, a FOXO1 
agonist may be an important therapeutic means to enhance the 
wound-healing response.
Results
Keratinocyte-specific FOXO1 deletion 
delays wound closure
To determine the role of FOXO1 in wound healing, we gener-
ated mice with deletion of FOXO1 in keratinocytes by breeding 
floxed FOXO1 mice with keratin 14 (K14) Cre-expressing 
mice. Small excisional wounds of 2.0 mm were made in the 
scalp of 16-wk-old K14.Cre+.FOXO1L/L mice and K14.Cre.
FOXO1L/L mice. Real-time PCR analysis of wounded mouse 
skin demonstrates an 80% loss of FOXO1 expression in the 
skin of K14.Cre+.FOXO1L/L mice compared with control 
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Figure 1. Keratinocyte-specific FOXO1 deletion delays wound closure. (A) Relative fold change of FOXO1 mRNA expression levels normalized to ribo-
somal protein L32 mRNA expression levels in the scalp wounds of control K14.Cre.FOXO1L/L and K14.Cre+.FOXO1L/L mice as measured by qRT-PCR. 
(B) FOXO1-immunostained sections (red) were counterstained with DAPI (blue). Bar, 100 µm. (C) Relative intensity measurements of FOXO1 immunostaining 
in the epithelium. (D) Quantification of FOXO1 nuclear localization in the wounded epithelium and normal epithelium on FOXO1-immunostained sections. 
(E) Representative photographs of scalp wounds on day 4 and 7 from K14.Cre.FOXO1L/L and K14.Cre+.FOXO1L/L mice. (F) Wound-healing process was 
analyzed at different time points after scalp wounding. Average wound area was presented as percentage of the wound area on day 0 (100%). (G) K14.
Cre.FOXO1L/L and K14.Cre+.FOXO1L/L mice were stratified into three groups: (1) high degree of healing (covering >70% of the original wound surface), 
light bars; (2) moderate (covering 30–70%), gray bars; or (3) little to no healing (covering >30%), dark bars. EP, epidermis; CT, connective tissues; White 
dashed lines demarcate the epidermis from the dermis. Asterisks indicate significant increase or decrease compared with control mice (P < 0.05). Error 
bars represent mean ± SEM, n = 6–9 per group.
 o
n
 April 2, 2015
jcb.rupress.org
D
ow
nloaded from
 
Published October 21, 2013
JCB • VOLUME 203 • NUMBER 2 • 2013 330
knocked down (P > 0.05; Fig. 3 A and  Fig. S1 C). Furthermore, 
we determined whether TGF-1 could rescue the effect of silenc-
ing FOXO1 in the in vitro wound-healing assay. At each time 
point TGF-1 treatment rescued the wound closure defect in 
FOXO1-silenced keratinocytes (P < 0.05; Fig. 3 B and Fig. S1 D), 
demonstrating that one of the principle mechanisms through 
which FOXO1 affects re-epithelialization in vitro is due to its im-
pact on keratinocyte migration mediated by TGF-1.
Because of the central importance of the above mechanism 
we then determined whether treatment with TGF-1 reversed 
the effect of FOXO1 knockdown on integrins that participate in 
migration. When FOXO1 was suppressed by RNAi, TGF-1 
stimulation led to a 130% increase in integrin 3 and 316% in-
crease in integrin 6 expression in FOXO1-silenced keratino-
cytes (P < 0.05; Fig. 3, C and D). Taken together, these results 
levels of genes involved in cell migration, including TGF-1 by 
61%, integrin 3 by 60%, integrin 6 by 84%, MMP-3 by 82%, 
and MMP-9 by 50% (P < 0.05; Fig. 2, H–L). We also noticed a 
33% decrease in ECM remodeling protein collagen IV (Fig. S5 A). 
In contrast, FOXO1 knockdown in human keratinocytes had no 
effect on proliferation (P > 0.05; Fig. S2, A–C).
TGF-1 treatment rescues the  
migration defect of keratinocytes  
with FOXO1 knockdown
To establish whether FOXO1 regulation of TGF-1 played a 
critical role in keratinocyte migration, a transwell migration assay 
was performed under conditions where FOXO1 was knocked 
down and TGF-1 rescue was performed. TGF-1 treatment 
completely reversed the migration defect when FOXO1 was 
Figure 2. FOXO1 silencing reduces closure of an in vitro scratch wound and keratinocyte migration. NHEK cells were transfected with control siRNA or 
siRNA specific for FOXO1 or FOXO3 for 48 h. QRT-PCR and Western blot analysis of FOXO1 (A and B) and FOXO3 (C and D) expression. (E) Quantita-
tive analysis of scratch wound closure at the indicated time points in FOXO1/FOXO3 knockdown cells. (F) Quantitative analysis of scratch wound closure at 
the indicated time points in FOXO1-overexpressed cells. (G) Transwell migration assay of cells transfected with control or FOXO1 siRNA; the migrated cells 
were photographed and counted. Real-time PCR analysis of TGF-1 (H), integrin 3 (I), integrin 6 (J), MMP-3 (K), and MMP-9 (L) mRNA levels in FOXO1 
knockdown keratinocytes. Data show mean ± SEM of at least three independent measurements per time point. Asterisks indicate significant increase or 
decrease compared with cells transfected with control siRNA (P < 0.05).
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Figure 3. TGF-1 treatment rescues the migration defect of keratinocytes with FOXO1 knockdown. NHEK cells were transfected with control or FOXO1 
siRNAs for 48 h and then treated with vehicle or TGF-1. (A) Transwell migration assay of cells transfected with control or FOXO1 siRNA; the migrated 
cells were stained with DAPI and photographed and counted. (B) Quantitative analysis of scratch-wound closure at the indicated time points in FOXO1 
knockdown cells without or with TGF-1. The mRNA levels of integrin 3 (C) and integrin 6 (D) were analyzed by real-time PCR. (E) Cell migration was 
assessed by transwell migration assay and the cells that have migrated across were stained with DAPI and photographed and counted. (F) ChIP assays 
for binding FOXO1 to the TGF-1 promoter were performed and ChIP-enriched DNA was quantified by qPCR with the indicated primers, and values are 
expressed as percentage of input DNA. (G) NHEK cells were cotransfected with a control pcDNA vector or a vector that expresses constitutively active 
FOXO1 (FOXO1AAA), control siRNA, or siRNA specific to FOXO1, together with TGF-1 reporter plasmid. Renilla luciferase reporter was used as an 
internal control. Luciferase activity was measured 36 h after transfection. Data show mean ± SEM of at least three independent experiments. *, P < 0.05 
vs. scrambled siRNA; +, P < 0.05 vs. siFOXO1; #, P < 0.05 vs. control pcDNA vector.
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a 2.6-fold decrease in TGF-1 promoter activity (P < 0.05; 
Fig. 3 G). Taken together, these results indicate that FOXO1 di-
rectly binds and transactivates TGF-1 promoter activity and 
confirms that TGF-1 is a downstream target of FOXO1.
FOXO1 knockdown results in increased 
keratinocyte apoptosis
To investigate whether FOXO1 knockdown affects keratinocyte 
apoptosis in vitro, we performed TUNEL assays (Fig. 4). 
Apoptosis was 2.4-fold higher in FOXO1 knockdown keratino-
cytes compared with the controls, whereas scrambled siRNA 
had no effect (P < 0.05; Fig. 4 A and Fig. S4). Results were con-
firmed using cell death detection ELISA (Fig. 4 B). Given that 
FOXO1 silencing enhanced keratinocyte apoptosis, we tested 
whether increased apoptosis was linked with increased expres-
sion of apoptotic genes. FOXO1 silencing significantly increased 
genes that promote apoptosis such as Bim by 73%, FAS ligand 
by 68%, and caspase 6 by 32% (P < 0.05; Fig. 4, C–E), indicat-
ing that constitutive FOXO1 expression protected against apop-
tosis and that FOXO1 in these cells functioned to decrease 
mRNA levels of pro-apoptotic genes. This is somewhat surpris-
ing because FOXO1 expression is associated with pro-apoptosis 
in most cell types (Ho et al., 2008), but in some cells, as demon-
strated here with keratinocytes, FOXO1 is needed to prevent 
apoptosis (Calnan and Brunet, 2008).
indicate that mRNA levels of integrins 3 and 6, which are im-
portant in keratinocyte migration, are regulated through FOXO1 
in a TGF-1–dependent manner and that delayed migration ob-
served in FOXO1 knockdown keratinocytes is due to attenuated 
TGF-1 signaling. To confirm that TGF-1 can stimulate kera-
tinocyte migration in an autocrine manner we silenced TGF-1 
by siRNA, which was verified by real-time PCR (Fig. S1 E). 
TGF-1 knockdown reduced keratinocyte migration by 45% 
in a transwell assay (P < 0.05; Fig. 3 E). This is consistent with 
previous reports that TGF-1 stimulates keratinocyte migration 
(Hebda, 1988; Kane et al., 1991; Gailit et al., 1994).
FOXO1 is recruited to the TGF-1 
promoter and transactivates its expression
The human TGF-1 promoter has two consensus FOXO1 bind-
ing elements at positions 192 bp (TTATTTCC) and 1263 bp 
(TTGTTTCC) upstream of the start codon in the TGF-1 pro-
moter (Furuyama et al., 2000). Chromatin immunoprecipitation 
(ChIP) assays showed that endogenous FOXO1 is recruited to 
the TGF-1 promoter (Fig. 3 F). To determine whether FOXO1 
can transactivate the TGF-1, we examined the luciferase activity 
of the TGF-1 reporter in primary keratinocytes. The luciferase 
reporter analysis revealed that overexpression of constitutively 
active FOXO1 (FOXO1AAA) results in a 2.5-fold increase in 
TGF-1 promoter activity, whereas FOXO1 silencing produced 
Figure 4. FOXO1 knockdown results in increased keratinocyte apoptosis. NHEK cells were transfected with control or FOXO1 siRNAs for 48 h. 
(A) Apoptotic keratinocytes were measured by TUNEL staining. Quantitative analysis of TUNEL-positive NHEK cells. The percentage of TUNEL-positive 
nuclei is reported as mean ± SD. (B) Apoptotic keratinocytes were confirmed by cell death detection ELISA. Real-time PCR analysis of Bim (C), FAS ligand 
(D), and caspase-6 (E) mRNA levels in FOXO1 knockdown keratinocytes. Data show mean ± SEM of at least three independent measurements. Asterisks 
indicate significant increase compared with cells transfected with siRNA control (P < 0.05).
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FOXO1 expression in keratinocytes results in decreased ex-
pression of antioxidative gens and GADD45, which repairs 
oxidative damage.
As an alternative mechanism, we examined whether the 
delayed scratch-wound closure in FOXO1-deficient keratino-
cytes is due to defects in glucose uptake or ATP production. 
However, we did not observe any changes in glucose uptake or 
ATP production in FOXO1-silenced keratinocytes compared 
with the controls (Fig. S2, D and E).
Decreased migration and proliferation, 
and increased apoptosis in keratinocytes 
isolated from FOXO1-deleted mice
To further establish the role of FOXO1 in regulating keratino-
cytes, experiments were performed with primary cells isolated 
from experimental K14.Cre+.FOXO1L/L and control K14.Cre.
FOXO1L/L mice. Western blot analysis showed that Cre recom-
binase reduced FOXO1 expression in experimental compared 
with control keratinocytes (Fig. 6 A). Furthermore, Western blot 
analysis for TGF-1 demonstrates the loss of TGF-1 expres-
sion at the protein level when FOXO1 is deleted (Fig. 6 A). 
Similarly, TGF-1 signaling measured by phosphorylation of 
SMAD2/3 was found to be decreased in K14.Cre+.FOXO1L/L 
keratinocytes, while the total SMAD2/3 protein levels remained 
the same (Fig. 6 A), indicating that the delayed wound-healing 
phenotype observed in FOXO1-deleted mice was due to de-
creased TGF-1 expression.
The effect of FOXO1 deletion on cell migration, proli-
feration, and apoptosis in vitro was examined using primary 
dermal keratinocytes isolated from K14.Cre.FOXO1L/L and 
K14.Cre+.FOXO1L/L mice. As shown in Fig. 6 B, deletion of 
FOXO1 resulted in a 50% decrease in cell migration compared 
with control keratinocytes. Deletion of FOXO1 also caused a 
twofold increase in apoptosis in keratinocytes isolated from ex-
perimental mice compared with control keratinocytes (Fig. 6 C). 
When proliferation was examined, FOXO1 deletion resulted in 
a small but significant 22% decrease in proliferation compared 
with wild-type keratinocytes (P < 0.05; Fig. 6 D). These results 
are very similar to those obtained by FOXO1 knockdown with 
specific siRNA.
Keratinocyte-specific FOXO1  
deletion results in decreased keratinocyte 
migration and proliferation and increased 
apoptosis in vivo
Further investigation of the role of FOXO1 in delayed wound 
healing was performed by histological analysis of specimens 
obtained from small excisional wounds created in K14.Cre.
FOXO1L/L and K14.Cre+.FOXO1L/L mice. Wound closure was 
significantly reduced by FOXO1 deletion in keratinocytes in 
vivo (Fig. 7 A). The gap between the edges of the epithelium 
was 2.5-fold larger in day-4 wounds of experimental K14.
Cre+.FOXO1L/L mice compared with matched K14.Cre.
FOXO1L/L control mice (P < 0.05; Fig. 7 B). This difference 
was fivefold on day 7 (P < 0.05; Fig. 7 F). Keratinocyte number 
was 1.5-fold higher in the wounds of control mice compared 
with experimental FOXO1-deleted mice (P < 0.05; Fig. 7, 
FOXO1 silencing enhances the impact of 
oxidative stress to reduce keratinocyte 
migration and enhance apoptosis
FOXO1 has been reported to protect cells against ROS such as 
H2O2 by activating various ROS detoxifying enzymes (Storz, 
2011). As shown in Fig. 5 A, loss of FOXO1 induced a 38% 
increase in ROS levels compared with controls. Incubation of 
keratinocytes with H2O2 enhanced ROS levels by 187% and 
silencing FOXO1 further enhanced H2O2-treated keratinocyte ROS 
levels by another 65%, whereas, treatment with N-acetyl-cysteine 
(NAC), a ROS inhibitor, markedly suppressed keratinocyte 
ROS levels (Fig. 5 A).
To determine the functional importance of FOXO1 in the 
response to oxidative stress, in vitro scratch-wound assays were 
performed. Silencing FOXO1 caused a 51% decrease in the 
number of keratinocytes that filled the “wound” gap at day 1 
(Fig. S3), a 54% decrease at day 2 (Fig. 5 B), and 39% reduction 
at day 3 (Fig. S3). Incubation of keratinocytes with H2O2 further 
decreased filling of the wound gap by an additional 24% at 
day 1 (Fig. S3), 56% at day 2 (Fig. 5 B), and 123% at day 3 
(Fig. S3). Furthermore, incubation of keratinocytes with the 
ROS inhibitor NAC rescued 75% of the wound closure defect 
observed in the FOXO1-silenced keratinocytes at day 2 (Fig. 5 B). 
In contrast, TGF-1 treatment had no effect on H2O2-suppressed 
scratch-wound closure with or without FOXO1 silencing (P > 
0.05; Fig. 5 B) and did not provide additional protection afforded 
by the antioxidant NAC (P > 0.05; Fig. 5 B). We further examined 
the effect of oxidative stress on keratinocyte migration by tran-
swell migration assay. As shown in Fig. 2 D, silencing FOXO1 
significantly impaired keratinocyte migration. Incubation with 
NAC rescued the negative impact of FOXO1 knockdown on kera-
tinocyte migration (Fig. 5 C). Incubation of keratinocytes with low 
amounts of H2O2 resulted in a 71% reduced migration of keratino-
cytes and silencing FOXO1 further decreased keratinocyte migra-
tion by another 18% (Fig. 5 C). Treatment of NAC reversed the 
inhibitory effect of H2O2 partially but significantly (Fig. 5 C). Con-
sistent with the scratch-wound assay, TGF-1 treatment had no 
effect on H2O2-suppressed keratinocyte migration (Fig. 5 C).
The effect of FOXO1 silencing and oxidative stress on 
keratinocyte apoptosis was examined. The antioxidant NAC 
rescued the pro-apoptotic effect of FOXO1 knockdown (P < 
0.05; Fig. 5 D). H2O2 increased keratinocyte apoptosis twofold 
relative to controls (P < 0.05), which was enhanced another 3.7-
fold by silencing FOXO1 (Fig. 5 D). TGF-1 had relatively lit-
tle effect on keratinocyte apoptosis (Fig. 5 D). Taken together, 
these results indicate that FOXO1 has an important antioxidant 
role that protects keratinocytes against ROS, which is critical 
for maintaining keratinocyte migration as well as protection 
against apoptosis. Moreover, this protection is largely indepen-
dent of TGF-1.
FOXO1 protects cells by stimulating antioxidant defense 
mechanisms such as glutathione peroxidases or inducing DNA 
repair enzymes such as GADD45. Silencing FOXO1 in kera-
tinocytes significantly decreased mRNA levels of antioxidant 
genes such as glutathione peroxidase 2 (GPX-2) by 49% and 
cytoglobulin by 39%, as well as DNA damage repair gene 
GADD45 by 64% (P < 0.05; Fig. 5, E–G). Thus, the loss of 
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To determine whether the effect of FOXO1 deletion in 
keratinocytes was due to altered migration, immunofluores-
cence was performed to measure the urokinase plasminogen 
activator receptor (uPAR), which is expressed in migrating 
C and G), which increased the area of healing epithelium (Fig. 7, 
D and H). We also observed a decrease in epithelial thickness 
by 25% (P < 0.05) in wounds of the FOXO1-deleted mice on 
day 4 (Fig. 7, E and I).
Figure 5. FOXO1 silencing enhances the impact of oxidative stress to reduce keratinocyte migration and increase apoptosis. NHEK cells were transfected 
with control or FOXO1 siRNAs for 48 h and then treated with 150 µM H2O2, 1 mM NAC, 2 ng/ml TGF-1, or various combinations of these agents. 
(A) Intracellular ROS were determined using the fluorescent probe CM-H2DCFDA staining. (B) Quantitative analysis of migrated cells after scratch wounds. 
(C) Transwell migration assay was carried as described in Materials and methods; the cells that have migrated across the transwells were stained with DAPI 
and photographed and counted. (D) Apoptotic keratinocytes were measured by TUNEL staining. Quantitative analysis of the percentage of TUNEL-positive 
nuclei is reported as mean ± SD. The mRNA levels of GPX2 (E), cytoglobulin (F), and GADD45 (G) were analyzed by real-time PCR. Data show mean ± 
SEM of at least three independent experiments. *, Significantly changed compared with scrambled siRNA; +, significantly changed compared with FOXO1 
siRNA in the no treatment group; #, significantly changed compared with the H2O2 plus FOXO1 siRNA. Significance set at P < 0.05.
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Fig. 8, G and H). These results indicate that deletion of FOXO1 
in keratinocytes in vivo enhances damage caused by oxidative 
stress. It is consistent with the in vitro studies (Fig. 5) support-
ing the notion that FOXO1 protection against oxidative stress is 
important in the cellular events of wound healing.
Loss of FOXO1 expression in  
keratinocytes leads to down-regulation of 
TGF-1 and reduced SMAD signaling
TGF-1 plays a critical role in re-epithelialization and wound 
repair (Werner and Grose, 2003). Experiments were performed 
to determine whether loss of FOXO1 in keratinocytes had an 
effect on the expression of TGF-1 in healing wounds of K14.
Cre.FOXO1L/L and K14.Cre+.FOXO1L/L mice. Control mice 
showed strong TGF-1 immunostaining in both basal and su-
prabasal cells in the wounded epithelium (Fig. 9 A). Deletion of 
FOXO1 in keratinocytes resulted in a 71% decrease in the num-
ber of keratinocytes that expressed TGF-1 in the wounds 
of experimental mice compared with control mice (P < 0.05; 
Fig. 9 B). These results showing FOXO1 regulation of TGF-1 
in in vivo are consistent with results above that FOXO1 regu-
lates TGF-1 production.
TGF-1 regulates its target gene expression through phos-
phorylation of its downstream signaling molecules, SMAD2/3. 
The number of keratinocytes with nuclear phospho-SMAD2/3 
decreased 42% in wounds of K14.Cre+.FOXO1L/L mice com-
pared with control mice (P < 0.05; Fig. 9, C and D), indicating 
that loss of FOXO1 expression in keratinocytes results in de-
creased TGF-1 signaling. However, total SMAD2/3 levels 
were not altered significantly (Fig. 9, E and F).
TGF-1 treatment rescues wound closure 
in FOXO1-deleted mice
To further investigate the role of TGF-1 in FOXO1-mediated 
wound healing, excisional wounds were treated topically with 
keratinocytes and is a marker of keratinocytes that are in the 
process of migrating (Lund et al., 2006). The expression of 
uPAR in keratinocytes was reduced 47% in the wounds of 
experimental K14.Cre+.FOXO1L/L mice compared with matched 
K14.Cre.FOXO1L/L control mice (P < 0.05; Fig. 8, A and B). 
The impact of FOXO1 on migrating keratinocytes during wound 
healing in vivo was similar to that observed in vitro. Previous 
studies suggest that hair follicles play important roles in normal 
wound healing (Lavker et al., 1993; Ito et al., 2005). Therefore, 
we examined the effect of keratinocyte-specific FOXO1 dele-
tion on indicators of cell migration in hair follicles. The number 
of uPAR-positive cells in hair follicles was reduced 54% in 
FOXO1-deleted mice compared with the control mice, indicat-
ing that deletion of FOXO1 in the keratinocytes affects the 
number of migrating hair follicle cells (Fig. 8 B).
We next investigated the effect of keratinocyte-specific 
FOXO1 deletion on keratinocyte apoptosis and proliferation 
in vivo. The percentage of apoptotic keratinocytes increased by 
1.6-fold in FOXO1-deficient wounds compared with control mice 
(P < 0.05; Fig. 8, C and D). In addition, we observed a 21% de-
crease in keratinocyte proliferation in the wound epithelium of 
FOXO1-deleted mice measured by the number of proliferating 
cell nuclear antigen (PCNA)–positive cells (Fig. 8, E and F; P < 
0.05). We also observed a 36% decrease in the number of PCNA-
positive hair follicle cells in FOXO1-deleted mice (Fig. 8 F).
Loss of FOXO1 expression in keratinocytes 
leads to enhanced oxidative stress in vivo
To examine whether there were changes in oxidative stress 
caused by FOXO1 deletion in keratinocytes in vivo we analyzed 
the expression of 8-hydroxy-2-deoxyguanosine (8-OHdG), 
a widely used marker of oxidative damage (Shigenaga et al., 
1989). The number of 8-OHdG–positive keratinocytes in-
creased 2.4-fold in healing wounds of K14.Cre+.FOXO1L/L mice 
compared with the control K14.Cre.FOXO1L/L mice (P < 0.05; 
Figure 6. Reduced migration and proliferation, and increased apoptosis in keratinocytes isolated from FOXO1-deleted mice. (A) Western blot analysis 
for FOXO1, TGF-1, phospho-SMAD2/3, SMAD2/3, and actin as loading control in K14.Cre.FOXO1L/L and K14.Cre+.FOXO1L/L keratinocytes. (B) Cell 
migration of K14.Cre.FOXO1L/L and K14.Cre+.FOXO1L/L keratinocytes was assessed by transwell migration assay; the migrated cells were stained with 
DAPI and photographed and counted. (C) Apoptotic keratinocytes were measured by TUNEL staining. (D) BrdU level of K14.Cre.FOXO1L/L and K14.Cre+.
FOXO1L/L keratinocytes. BrdU incorporation was determined by measuring absorbance at 450 nm. Data show mean ± SEM of at least three independent 
experiments. *, P < 0.05 vs. K14.Cre.FOXO1L/L keratinocytes.
 o
n
 April 2, 2015
jcb.rupress.org
D
ow
nloaded from
 
Published October 21, 2013
JCB • VOLUME 203 • NUMBER 2 • 2013 336
controls the cellular events of wound healing. A summary of the 
cellular events regulated by FOXO1 in keratinocytes in vitro and 
in vivo are shown in Table 1.
Discussion
FOXO1 has been shown to play an important role in cellular 
processes that are linked to repair, particularly inhibiting prolif-
eration, increasing apoptosis, and reducing oxidative stress. 
However, its role in regulating keratinocytes and keratinocyte 
behavior in wound healing has not been investigated. Based 
upon the effects of FOXO1 we anticipated that deletion of 
FOXO1 would enhance wound healing by increasing prolifera-
tion and reducing apoptosis. To test this we performed wound-
healing experiments both in vivo using a conditional deletion of 
FOXO1 in a keratinocyte lineage as well as in vitro. Unexpect-
edly, mice with FOXO1 deletion in keratinocytes exhibited im-
paired wound closure in vivo and also displayed very similar 
either recombinant TGF-1 or vehicle. TGF-1 treatment en-
hanced wound closure. On day 4, wounds were 58% larger in the 
vehicle-treated compared with the TGF-1–treated in K14.Cre+.
FOXO1L/L mice (P < 0.05; Fig. 10, A and B). On a histological 
level TGF-1 treatment rescued the wound-healing defect in 
FOXO1-deleted mice by decreasing the size of the epithelial gap 
by 75% and enhancing the size of the healing epithelium mea-
sured by epithelial length and thickness (Fig. 10, C–G). FOXO1-
deleted mice treated with TGF-1 also had a 2.4-fold increase in 
the number of migrating cells in the wounded epithelium and a 
twofold increase in the number of migrating cells in hair follicles 
(Fig. 10, H and I). However, there was no significant differ-
ence in proliferating keratinocytes when TGF-1–treated wounds 
were compared with vehicle-treated wounds in FOXO1-deleted 
mice (P > 0.05; Fig. 10 J). Thus, the negative effect of FOXO1 
deletion was rescued by TGF-1 treatment in vivo as was also 
noted in vitro. This further links the functional importance of 
FOXO1 regulation of TGF-1 as a mechanism by which FOXO1 
Figure 7. Delayed wound healing in keratinocyte-specific FOXO1-deleted mice. (A) Hematoxylin and eosin (H&E) staining of K14.Cre.FOXO1L/L and 
K14.Cre+.FOXO1L/L mice wound biopsies on day 4 after wounding. Bar, 500 µm. WC, wound center; WE, wound epithelium; Normal, normal epithelium. 
Quantification of epithelial migration and re-epithelialization in the day-4 and day-7 scalp wounds. The gap between epithelium (B and F), number of cells 
in the wound epithelium (C and G), epithelial area (D and H), and epithelial thickness (E and I) was assessed by image analysis of H&E-stained sections at 
the center of each wound. EP, epidermis; CT, connective tissues. Each value is the mean ± SEM for n = 6–9 mice per group. Asterisks indicate significant 
increase or decrease compared with control mice (P < 0.05).
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Figure 8. Loss of FOXO1 expression in keratinocytes results in decreased keratinocyte migration and proliferation and increased apoptosis. Paraffin-em-
bedded cross sections from K14.Cre.FOXO1L/L and K14.Cre+.FOXO1L/L mice were analyzed by immunofluorescence using an anti-uPAR antibody (A), 
anti-PCNA antibody (E), or anti-8-OHdG antibody (G), and by TUNEL assay (C). Quantification of uPAR-positive migrating keratinocytes (B), TUNEL-positive 
apoptotic keratinocytes (D), PCNA-positive proliferative keratinocytes (F), and 8-OHdG–positive keratinocytes (H). Bars: (A and G) 100 µm; (C and E) 200 µm. 
EP, epidermis; CT, connective tissues. White dashed lines demarcate the epidermis from the dermis. Each value is the mean ± SEM for n = 6–9 mice per 
group. Asterisks indicate significant changes compared with control mice (P < 0.05).
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Figure 9. Reduced TGF-1 and phospho-SMAD2/3 expression in the FOXO1-deleted mice keratinocytes. Paraffin-embedded cross sections from K14.
Cre.FOXO1L/L and K14.Cre+.FOXO1L/L mice were analyzed by immunofluorescence using (A) anti–TGF-1 antibody, (C) phospho-SMAD2/3 anti-
body, and (E) anti-SMAD2/3 antibody. Quantitative analysis of (B) TGF-1–positive keratinocytes, (D) phospho-SMAD2/3–positive keratinocytes, and (F) 
SMAD2/3-positive keratinocytes. Bar, 100 µm. EP, epidermis; CT, connective tissues. White dashed lines demarcate the epidermis from the dermis. Each 
value is the mean ± SEM for n = 6–9 mice per group. Asterisks indicate significant changes compared with control mice (P < 0.05).
results in an in vitro model of wound healing. Delayed wound 
healing caused by FOXO1 deletion was primarily caused by a 
decrease in migrating keratinocytes both in the wounded epi-
thelium and in hair follicles. We determined that a primary 
downstream event regulated by FOXO1 was TGF-1 expres-
sion and that wound healing impaired by FOXO1 deletion could 
be rescued by treatment with TGF-1 in vivo and in vitro. Thus, 
FOXO1 is required for the up-regulation of TGF-1 in wound 
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Figure 10. TGF-1 treatment rescues impaired wound closure in FOXO1-deleted mice. (A) Representative photographs of scalp wounds on day 4 and day 7 
from K14.Cre.FOXO1L/L and K14.Cre+.FOXO1L/L mice treated with vehicle or TGF-1. (B) Wound-healing process was analyzed at different time points 
after wounding. Average wound area was presented as percentage of the wound area on day 0 (100%). (C) Hematoxylin and eosin staining of K14.Cre.
FOXO1L/L and K14.Cre+.FOXO1L/L mice wound biopsies on day 7 after wounding. Bar, 500 µm. WC, wound center; WE, wound epithelium; Normal, 
normal epithelium. The quantification of epithelial migration and re-epithelialization in the day-7 scalp wounds of K14.Cre.FOXO1L/L and K14.Cre+.
FOXO1L/L mice. The gap between epithelium (D), epithelial length (E), epithelial area (F), and epithelial thickness (G) was assessed by image analysis of 
hematoxylin and eosin–stained sections at the center of each wound. Paraffin-embedded cross sections from K14.Cre.FOXO1L/L and K14.Cre+.FOXO1L/L 
mice were treated with either vehicle or TGF-1 and were analyzed by immunofluorescence using an anti-uPAR antibody and anti-PCNA antibody. Percent-
age of uPAR-positive migrating keratinocytes was quantified in normal and wound epithelium (H) as well as in hair follicles (I). (J) PCNA-positive proliferative 
keratinocytes in wound epithelium. EP, epidermis; CT, connective tissues; *, P < 0.05. Error bars represent mean ± SEM, n = 4–6 mice per group.
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healing. That this is a critical event is supported by findings that 
TGF-1 is needed for normal wound healing, and when absent, 
wound healing is significantly retarded (Werner and Grose, 2003).
Several lines of evidence indicate that FOXO1 regulates 
TGF-1 in keratinocytes. Cre recombinase deletion of FOXO1 
in keratinocytes in vivo substantially reduced the expression of 
TGF-1 with a corresponding decrease in phosphorylation of 
its downstream effectors SMAD2/3. The latter provides evi-
dence for the biological activity of FOXO1-regulated TGF-1. 
In vitro knockdown of FOXO1 by RNAi substantially reduced 
TGF-1 mRNA levels and decreased TGF-1 promoter activ-
ity, and Cre recombinase deletion of FOXO1 in mouse primary 
keratinocytes reduced TGF-1 protein levels. Conversely, over-
expression of constitutively active FOXO1 significantly in-
creased TGF-1 promoter activity in luciferase reporter assays. 
ChIP assays indicate that FOXO1 directly binds to the TGF-1 
promoter. Silencing TGF-1 reduced keratinocyte migration, in-
dicating that TGF-1 acts as an autocrine factor to enhance mi-
gration of these cells. This is consistent with previous reports that 
TGF-1 stimulates keratinocyte migration (Hebda, 1988; Kane 
et al., 1991; Gailit et al., 1994). Moreover, TGF-1 treatment 
rescued impaired migration of keratinocytes with FOXO1 knock-
down in a transwell assay and in an in vitro scratch assay. TGF-1 
treatment also reversed impaired keratinocyte migration but not 
proliferation in vivo and rescued impaired healing in mice with 
conditional deletion of FOXO1 in vivo. These results agree with 
previous studies that TGF-1 regulates keratinocyte migration 
and wound re-epithelialization (Hebda, 1988; Zambruno et al., 
1995). Thus, FOXO1 is needed for adequate TGF-1 expression 
and normal keratinocyte migration and wound healing.
Keratinocyte migration requires the up-regulation of inte-
grins and MMPs (Gailit et al., 1994; Zambruno et al., 1995; 
Hsieh et al., 2010). Our data demonstrate that FOXO1 defi-
ciency in keratinocytes significantly attenuated the expression 
of integrins-6 and -3 needed for wound re-epithelialization 
(Huang et al., 1998). In addition, silencing of FOXO1 decreased 
mRNA levels of matrix metalloproteinases MMP-3 and MMP-9 
in keratinocytes that facilitate keratinocyte migration and wound 
healing (Agren, 1999). Thus, FOXO1 is needed to maintain ex-
pression of integrins and MMPs that are required for optimal 
keratinocyte migration and wound healing. In addition, silenc-
ing FOXO1 reduced basement membrane protein collagen IV, 
indicating that deletion of FOXO1 could have direct or indirect 
effects on wound healing that are due to altered basement mem-
brane protein production.
Table 1. Effect of FOXO1 deletion or knockdown
Phenotype In vivo In vitro
Wound healing Decrease Decrease
Migration Decrease Decrease
Apoptosis Increase Increase
ROS or Ox damage Increase Increase
Proliferation Decrease Decrease or  
No change
TGF-1 expression Decrease Decrease
We examined alternative mechanisms by which FOXO1 
could affect wound healing. The formation of reactive oxygen 
species and the level of oxidative stress are increased in healing 
wounds (Schäfer and Werner, 2008; Guo and Dipietro, 2010). 
When normal levels of ROS are exceeded, such as in diabetic 
wound healing, excessive oxidative stress occurs and causes a 
decrease in keratinocyte proliferation and migration and in-
creased apoptosis (Nishio and Watanabe, 1997; Wenk et al., 1999; 
Deveci et al., 2005). We found that the loss of FOXO1 expression 
in keratinocytes in vitro increased ROS levels and deletion of 
FOXO1 in keratinocytes in vivo resulted in increased oxidative 
damage in healing wounds as measured by a marker of oxidative 
damage, 8-OHdG (Shigenaga et al., 1989). We showed two addi-
tional mechanisms through which elevated ROS levels caused by 
reduced expression of FOXO1 limits the wound-healing behavior 
of keratinocytes. The increased susceptibility to oxidative stress 
caused by FOXO1 deletion is directly linked to impaired cell mi-
gration because it can be rescued by treatment with an antioxi-
dant, NAC. Under mild oxidative stress caused by deletion of 
FOXO1, TGF-1 was also able to rescue impaired migration, but 
under more severe oxidative stress such as H2O2 combined with 
FOXO1 deletion it did not. Thus, FOXO1 affects keratinocyte 
migration through two mechanisms, regulation of TGF-1 and 
protection against the anti-migratory effect of elevated ROS. In 
addition, FOXO1 protection against ROS is needed to reduce oxi-
dative damage and reduce keratinocyte apoptosis. An increase in 
both is linked to impaired wound healing (Soneja et al., 2005; Sen 
and Roy, 2008).
FOXO1 activity protects cells against oxidative stress by 
activating antioxidant defense mechanisms such as MnSOD 
and glutathione peroxidases (van der Horst and Burgering, 
2007; Storz, 2011). The expression of antioxidant genes such as 
glutathione peroxidase 2 and cytoglobulin were down-regulated 
in FOXO1-silenced keratinocytes in vitro. Another mechanism 
by which FOXO1 is protective is by modulating the expression 
of the DNA repair enzyme, GADD45, which repairs DNA 
damaged by oxidative stress (Furukawa-Hibi et al., 2002; Tran 
et al., 2002). GADD45 had reduced expression in FOXO1- 
silenced keratinocytes. Collectively, these data indicate that loss 
of FOXO1 expression in keratinocytes results in increased ROS 
levels and decreased antioxidant deference mechanisms, lead-
ing to reduced keratinocyte migration and increased apoptosis. 
Although in a number of cell types FOXO1 promotes apoptosis, 
several lines of evidence suggest that FOXO1 plays a central 
role in cell survival during conditions of oxidative stress through 
up-regulation of antioxidant enzymes and regulation of cell sur-
vival pathways (Burgering and Medema, 2003; Tothova et al., 
2007; Sengupta et al., 2011). Our results are in agreement with 
previous results that FOXO1 can protect against cellular oxida-
tive stress (Ponugoti et al., 2012).
FOXO1 is also known to affect progression through the 
cell cycle. We determined that in vitro FOXO1 deletion had 
only a small effect by slightly reducing proliferation of primary 
mouse keratinocytes, and in primary human keratinocytes 
FOXO1 deletion had no effect. In addition, FOXO1 silencing 
had little effect on mRNA levels of cell cycle regulators tested 
such as cyclin D1 and D2, and CDK1, 2, and 4. In vivo FOXO1 
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streptavidin, and counterstained with DAPI. For immunohistochemistry, anti-
body was localized by incubation with avidin–biotin horseradish peroxi-
dase complex using a biotinylated secondary antibody. To enhance the 
signal, tyramide signal amplification was used that enhances the chromo-
genic signal (PerkinElmer). Apoptosis was assessed by the DeadEnd Fluoro-
metric TUNEL System (Promega).
Microscopy
Sections were observed with 4× and 20× objectives and images were ac-
quired using a fluorescence microscope (Eclipse 90i; Nikon) and a Cool-
Snap EZ camera (Photometrics). All images were taken at room temperature 
with a TXRED or FITC filter. Image analysis was performed using Nikon AR 
image analysis software.
Cell culture and siRNA transfections
Primary cultures of human epidermal keratinocytes (NHEK) were purchased 
and maintained in KGM-2 growth medium (Lonza) supplemented with 
0.1 ng/ml hEGF, 5.0 µg/ml insulin, 0.5 µg/ml hydrocortisone, 0.15 mM 
calcium, 5 ng/ml epinephrine, 10 µg/ml transferrin, and 2 ml bovine pitu-
itary extract. All cells were grown in a humidified atmosphere with a 5% 
CO2 concentration. ON-TARGETplus SMARTpool siRNAs against FOXO1, 
FOXO3, TGF-1, and control siRNA were obtained from Thermo Fisher 
Scientific. DNA transfections were performed using Lipofectin (Invitrogen) 
and siRNA transfections were performed using GeneMute siRNA transfec-
tion reagent (Signagen).
In vitro wound-healing and transwell migration assay
NHEK cells were transfected with FOXO1 or scrambled siRNA 48 h before 
assay. For in vitro wounds, confluent cells were ”scratched” using a 200-µl 
pipette tip as described previously (Liang et al., 2007) and photographs 
were taken as indicated to assess the number of keratinocytes that had mi-
grated into the wounded area. For the migration assay, 2 × 105 cells were 
incubated in the upper chamber of a transwell (Corning Costar; Thermo 
Fisher Scientific) containing a polycarbonate membrane filter (6.5-mm diam-
eter, 8-µm pore size). After 6 h, cells remaining in the upper surface of the 
membrane were removed and migrated cells on the lower surface of the 
membrane were counted after staining with DAPI. In some cases, cells were 
treated with 150 µM H2O2, 1 mM N-acetyl-cysteine (NAC), 2 ng/ml TGF-1, 
or various combinations of these agents. Experiments were performed at least 
three times.
Real-time PCR
Real-time PCR was performed essentially as described previously (Siqueira 
et al., 2010). Total RNA was isolated from confluent NHEK cells following 
the manufacturer’s instructions (RNeasy; QIAGEN). 1 µg of total RNA was 
reverse transcribed using High Capacity RNA-to-cDNA kit (Applied Biosys-
tems), and real-time PCR was performed using the Universal Probe Library 
System (Roche). All primers were designed using the Universal Probe Library 
Assay Design Center (Roche). Results were normalized with mitochondrial 
ribosomal protein L32. Each experiment was performed 2–4 times with simi-
lar results.
Western blot
Epithelial cells were lysed with lysis buffer (Thermo Fisher Scientific) contain-
ing protease inhibitor cocktail and phosphatase inhibitor cocktail (Thermo 
Fisher Scientific). Protein concentration was measured using a protein assay 
with BSA as a standard (Bio-Rad Laboratories). 50 µg cell lysate was resolved 
in 4–20% SDS-PAGE (Bio-Rad Laboratories) and transferred onto PVDF mem-
brane (Thermo Fisher Scientific). The membranes were incubated with pri-
mary antibodies against FOXO1 (Santa Cruz Biotechnology, Inc.), FOXO3 
(Cell Signaling Technology), TGF-1 (Promega), p-SMAD2/3 (Santa Cruz 
Biotechnology, Inc.), SMAD2/3 (Santa Cruz Biotechnology, Inc.), and -actin 
(Sigma-Aldrich) after blocking with 5% BSA. The samples were then incu-
bated with horseradish peroxidase–labeled anti–rabbit IgG or anti–mouse 
IgG, and immunoreactive bands were detected with ECL Western blotting re-
agents (Thermo Fisher Scientific).
ChIP assays
ChIP assays were performed using ChIP-IT kit (Active Motif) following the man-
ufacturer’s instructions, as described previously (Alblowi et al., 2009). Isolated 
DNA was subjected to quantitative real-time PCR by using primers specific for 
the TGF-1 promoter with a Universal Probe Library Probe (Roche). The TGF-
1 promoter primer sequences used were: set 1 (left, 5-CCATGTTGACA-
GACCCTCCT-3; right, 5-TTAATCCGGGGGATGAGAC-3); set 2 (left, 
5-TAAGACGGTGGGAGCCTAGA-3; right, 5-GGCCCAGTCTTTTCCTC-
TCT-3). ChIP experiments were repeated three times with reproducible results.
deletion caused a small reduction in keratinocyte proliferation 
in vivo. This suggests that FOXO1 has only a minor effect on 
regulating the cell cycle of keratinocytes in wound healing.
In summary, we unexpectedly found that FOXO1 promotes 
healing because it is needed for keratinocyte transition to a 
wound-healing phenotype that involves migration and up-regula-
tion of TGF-1 and its downstream targets, integrin-3 and -6 
and matrix metalloproteinase-3 and -9. The negative effect of 
FOXO1 deletion both in vitro and in vivo was rescued by treat-
ment with TGF-1. The impact of FOXO1 deletion on keratino-
cyte migration in vitro was also reversed by an antioxidant in a 
TGF-1–independent manner. Lastly, FOXO1 deletion increased 
susceptibility to ROS-mediated apoptosis. This change was linked 
to the up-regulation of genes that protect against oxidative dam-
age and prevent apoptosis. Thus, treatment with FOXO1 agonists 
may represent a potential therapeutic target for enhancing tissue 
repair by mobilizing keratinocytes for rapid wound epithelializa-
tion and protecting them from oxidative stress.
Materials and methods
Mice
Mice expressing a floxed allele of FOXO1 were provided by R.A. DePinho 
(MD Anderson Cancer Center, Houston, TX) and have been previously de-
scribed (Paik et al., 2007). The second major coding exon (encoding the 
C-terminal half of FOXO1) was targeted by the insertion of loxP sites and mice 
were backcrossed three times onto the FVBn background. Mice expressing 
keratin 14-Cre (strain Tg(KRT14-cre)1Amc/J) were obtained from the Jackson 
Laboratory. These mice were bred to generate experimental (K14.Cre+.
FOXO1L/L) and control (K14.Cre.FOXO1L/L) mice and experiments were 
performed using mice 16–20 wk of age. Mice with floxed allele of FOXO1, 
K14.Cre.FOXO1L/L, and K14.Cre+.FOXO1L/L developed normally and did 
not show any sign of disease. All mice were maintained in a regular 12-h 
day–night cycle. All the animal experiments were approved by the University 
of Pennsylvania Institutional Animal Care and Use Committee.
In vivo wound-healing experiments
Mice were anaesthetized by i.p. administration of ketamine (80–100 mg/kg) 
and xylazine (5–10 mg/kg); the scalp hair was shaved, cleansed, and two 
excisional wounds of 2.0 mm were created in the scalp at the midline with 
a sterile dermal punch as described previously (Siqueira et al., 2010). 
Wounds were photographed and animals euthanized to collect the wounded 
tissue at the indicated time points. For TGF-1 treatment, mice were treated 
topically with 100 ng of recombinant TGF-1 (PeproTech) in 3% methylcellu-
lose or vehicle alone at the time of wounding and every second day there-
after. In all in vivo experiments 6–9 mice per group were examined at each 
time point and the value per animal was the unit of measurement.
Histological analysis
The scalp and attached calvarial bone were fixed in 4% paraformalde-
hyde for 24 h, decalcified in 10% EDTA solution, embedded in paraffin, 
and sectioned at 5 µm. Sections were stained with hematoxylin and eosin 
(H&E) and histomorphometric analysis was performed with computer- 
assisted image analysis at the center of each lesion. We measured param-
eters such as epithelial gap, epithelial cell number, epithelial area, and 
epithelial thickness at the wound site.
Immunohistochemistry, immunofluorescence, and apoptosis  
in histological sections
Antigen retrieval was performed by heating slides in 10 mM sodium citrate 
(pH 6.0) for 5 min at 95°C. Sections were then incubated with primary an-
tibody against FOXO1 (Santa Cruz Biotechnology, Inc.), proliferating cell 
nuclear antigen (PCNA; Santa Cruz Biotechnology, Inc.), urokinase-type 
plasminogen activator receptor (uPAR; Santa Cruz Biotechnology, Inc.), 
8-hydroxydeoxyguanosine (8-OHdG; EMD Millipore), TGF-1 (Abcam), 
phospho-SMAD2/3 (Santa Cruz Biotechnology, Inc.), and SMAD 2/3 
(Santa Cruz Biotechnology, Inc.) or matched nonimmune primary antibody 
overnight at 4°C. For immunofluorescence, antibody was localized by a bi-
otinylated secondary antibody and visualized using Alexa 546–conjugated 
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Luciferase reporter assay
Luciferase activity was measured using the Dual Luciferase Reporter Assay kit 
(Promega) according to the manufacturer’s instructions. In brief, NHEK cells 
were cotransfected with plasmid DNA of TGF-1-Luc, Renilla-Luc, pcDNA-
FOXO1AAA, scramble, or FOXO1 siRNA. Empty vector DNA was added as 
needed so that the same amounts of expression vector were present in each 
transfection. Transfection was performed using Lipofectin (Invitrogen) in 24-
well plates. 24 h after transfection, cells were lysed, and luciferase and Renilla 
activities were measured using a luminometer (Infinite M200; Tecan). Firefly 
luciferase activities were divided by Renilla activities to normalize for transfec-
tion efficiency. Experiments were performed three times with similar results.
ROS assay
The cellular ROS levels were measured by using chloromethyl-2’7’-dichlorodi-
hydrofluorescein diacetate acetyl ester (CM-H2DCFDA) following the manu-
facturer’s instructions (Invitrogen). NHEK cells were transfected with FOXO1 
or scrambled siRNA for 48 h in 96-well plates and then treated with 150 µM 
H2O2, 1 mM NAC, 2 ng/ml TGF-1, or various combinations of these agents. 
After 16 h, cells were incubated with 10 µM CM-H2DCFDA for 30 min at 
37°C and fluorescent intensity was recorded by excitation at 492 nm and 
emission at 527 nm using a plate reader (Infinite M200; Tecan). Experiments 
were performed three times with similar results.
BrdU incorporation assay
Detection of BrdU incorporation was performed by ELISA using the BrdU Cell 
Proliferation Assay kit (Cell Signaling Technology) according to the manufactur-
er’s instructions. In brief, 2.5 × 103 cells were seeded onto 96-well plates and 
incubated with 10 µM BrdU. The cells were then fixed and incubated with anti-
BrdU antibody. BrdU incorporation was determined by measuring absorbance 
at 450 nm. Experiments were performed three times with similar results.
Apoptosis in vitro
Apoptosis were measured by ELISA for cytoplasmic histone-associated DNA 
(Roche) according to the manufacturer’s instructions. In brief, NHEK cells 
were transfected with FOXO1 or scrambled siRNA for 48 h and seeded onto 
96-well plates and cell lysates were analyzed in the ELISA. Apoptotic cells 
were also identified by the DeadEnd Fluorometric TUNEL System (Promega) 
following the manufacturer’s instructions. Experiments were performed three 
times with similar results.
Glucose uptake assay
To measure glucose uptake, NHEK cells transfected with scrambled siRNA or 
FOXO1 siRNA were incubated with 200 µM 2-(N-(7-nitrobenz-2-oxa-1,3-diazol- 
4-yl)amino)-2-deoxyglucose (2-NBDG; Invitrogen) for 30 min, washed three 
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formed using Modfit software (Verity Software House). Experiments were per-
formed three times with similar results.
ATP determination assay
The intracellular ATP levels were measured using the ATP Determination kit 
(Molecular Probes; Invitrogen) in a luminometer (Infinite M200; Tecan), follow-
ing the manufacturer’s instructions. The protein concentration was measured 
using the BCA Protein Assay kit (Thermo Fisher Scientific). The relative ATP lev-
els were normalized with the protein concentration. Experiments were per-
formed three times with similar results.
Statistics
Statistical analysis between two groups was performed using two-tailed Stu-
dent’s t test. In experiments with multiple time points or treatments, differences 
between the wild-type and experimental groups were determined by one-way 
ANOVA with Scheffe’s post-hoc test. Results are expressed as the mean ± 
SEM. P < 0.05 was considered statistically significant.
Online supplemental material
Fig. S1 shows the images from scratch-wound and transwell migration as-
says of FOXO1 knockdown cells. Fig. S2 shows the effect of FOXO1 
knockdown on proliferation, glucose uptake, or ATP production in keratino-
cytes. Fig. S3 shows that increased oxidative stress impairs keratinocyte 
migration of in vitro scratch wound. Fig. S4 contains images of TUNEL 
assay and shows that silencing FOXO1 results in increased apoptosis. Fig. S5 
shows that silencing FOXO1 in keratinocytes results in decreased collagen 
IV1 mRNA levels. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.201305074/DC1.
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Figure S1.  Effect of FOXO1/FOXO3 knockdown on keratinocyte migration in the absence and presence of TGF- b1. (A) Photomicrographs of scratch clo-
sure at the indicated time points in NHEK control cultures or FOXO1/FOXO3 knockdown cells after scratch wounding. Bar, 500 µm. (B and C) Cell migra-
tion was assessed by transwell migration assay; the cells that migrated across the transwells were stained with DAPI and the migrated cells were 
photographed. Bar, 200 µm. (D) Photomicrographs of scratch closure at the indicated time points in FOXO1 knockdown cells without or with TGF-1 after 
scratch wounding. Bar, 500 µm. (E) NHEK cells were transfected with control or TGF-1 siRNAs for 48 h. TGF-1 levels were analyzed by real-time PCR. 
*, P < 0.05 vs. scrambled siRNA.
JCB S2 
Figure S2.  Effect of FOXO1 knockdown on proliferation, glucose uptake, or ATP production in keratinocytes. NHEK cells were transfected with control or 
FOXO1 siRNAs for 48 h. (A) Proliferative keratinocytes were determined by PCNA immunofluorescence or (B) BrdU ELISA. BrdU incorporation was deter-
mined by measuring absorbance at 450 nm. (C) Real-time PCR analysis of cyclin D1, cyclin D2, CDK1, CDK2, and CDK4 mRNA levels in FOXO1 knock-
down keratinocytes. (D) Cells were incubated with 2-NBDG and the amount of NBDG uptake was measured by flow cytometry. (E) Intracellular ATP levels 
were measured using ATP determination kit. a.u., arbitrary units. Data show mean ± SEM of at least three independent measurements.
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Figure S3.  Increased oxidative stress impairs keratinocyte migration of in vitro scratch wound. NHEK cells were transfected with control or FOXO1 siRNA 
for 48 h and then treated with 150 µm H2O2, 1 mM NAC, 2 ng/ml TGF-1, or various combinations of these agents after scratching. The number of cells 
in the scratched area was counted. Data show mean ± SEM of at least three independent measurements. *, P < 0.05 vs. scrambled siRNA; +, P < 0.05 vs. 
siFOXO1; #, P < 0.05 vs. H2O2-treated siFOXO1.
Figure S4.  FOXO1 knockdown results in increased keratinocyte apoptosis. NHEK cells were transfected with control or FOXO1 siRNAs for 48 h. Apop-
totic keratinocytes were measured by TUNEL staining. Green fluorescence indicates TUNEL-positive cells. Blue fluorescence indicates DAPI nuclear staining. 
Bar, 200 µm.
JCB S4 
Figure S5.  Silencing FOXO1 in keratinocytes results in decreased collagen IV1 mRNA levels. NHEK cells were transfected with control or FOXO1 siRNAs 
for 48 h. (A) Real-time PCR analysis of collagen IV1 mRNA levels in FOXO1 knockdown keratinocytes. *, P < 0.05 vs. scrambled siRNA.
